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Several post-translational modifications in host cells are hijacked by pathogens to
facilitate their propagation. A number of components of the influenza virus have been
reported to be modified by small ubiquitin-like modifier (SUMO) proteins during infection.
We hypothesized that the MAPK/ERK pathway could be modified by SUMO1 because
the SUMOylation of MEK1 was quickly eliminated after influenza A virus infection. We
identified host cell MEK1 as a target of SUMO1 through LC/MS/MS, and enhanced
MEK1 SUMOylation inhibited the infection of the virus, while inhibition of host cell
MEK1 SUMOylation facilitated virus propagation. Further investigation demonstrated that
the MAPK/ERK pathway is downregulated by MEK1 SUMOylation, which is inhibited
by influenza virus infection. Furthermore, membrane accumulation of hemagglutinin
promoted MEK1 phosphorylation and gradually abrogated the MEK1 SUMOylation.
Taken together, we report a possible mechanism in which HA may trigger the ERK
pathway in influenza A virus-infected cells as the switch from MEK1 SUMOylation to
phosphorylation, facilitating virus infection.
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INTRODUCTION
Influenza A viruses can be highly contagious pathogens for both humans and several animal
species. In support of their efficient replication within host cells, the viruses interact with a
variety of host proteins and hijack cellular responses to antagonize several cellular pathways
at different stages (Pleschka et al., 2001; Ludwig et al., 2006; Szretter et al., 2007). The post-
translational conjugation of the Small Ubiquitin-like Modifier (SUMO) proteins to target proteins
(SUMOylation) is an important mechanism for the regulation of protein activity, stability, cellular
localization, and protein-protein interactions (Jürgen, 2004; Geiss-Friedlander and Melchior,
2007). Previous reports have indicated that influenza A virus interacts extensively with the cellular
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SUMOylation system during infection, and NS1, NS2, PB1, NP,
andM1 proteins were targets of the cellular SUMOylation system
(Pal et al., 2010, 2011; Xu et al., 2011). However, whether the
host cellular SUMOylation status is affected by influenza A virus
infection remains unexplored.
In eukaryotic cells, various extracellular stimuli generate
intracellular signals that converge on a limited number of
conserved protein kinase cascades, commonly referred to as the
mitogen-activated protein kinase (MAPK) pathway. The MAPK
cascade is recognized as a hallmark signaling pathway activated
by influenza viruses (Pleschka et al., 2001), including the highly
pathogenic avian influenza virus H5N1 (Droebner et al., 2011).
The Raf/MEK/ERK signal cascade, which is activated during late
influenza infection, is essential for efficient export of nuclear
RNPs (Pleschka et al., 2001). Blockade of this pathway by specific
inhibitors of MEK, or a dominant-negative growth of ERK or
Raf resulted in a strongly impaired proliferation of influenza
virus and retarded RNP export (Pleschka et al., 2001; Ludwig
et al., 2006). Another study suggested that activation of the
Raf/MEK/ERK cascade lead to efficient RNP export as well as
virus production, achieved by the accumulation of the viral
HA on the cell surface and enhanced viral polymerase activity
(Marjuki et al., 2007). A detailed mechanism of the activation of
the MAPK cascade and its relationship to SUMOylation remains
elusive.
Because the host cellular SUMOylation system was hijacked
by virus infection to modify numerous viral protein (Santos
et al., 2013), the host cellular SUMOylation status might also
be influenced by influenza virus infection. To better understand
influenza virus-host interactions, we identified host cell MEK1
as a target of SUMO1, and the SUMOylation of MEK1 could
be regulated by influenza A virus H5N1 infection. Enhanced
MEK1 SUMOylation inhibited the infection of the virus,
whereas downregulated-MEK1 SUMOylation facilitated virus
propagation. Further investigation suggested that influenza virus
infection impairs the MAPK/ERK (also called Ras-Raf-MEK-
ERK) pathway by downregulating MEK1 SUMOylation. This
study proposes a novel mechanism for influenza viruses to
dampen the host response by abrogating the SUMOylation level
of MEK1 to facilitate viral RNP export through the MAPK/ERK
pathway.
MATERIALS AND METHODS
Viruses, Cells, and Plasmid Constructs
Influenza virus A/environment/Qinghai/1/2008 (H5N1) was
propagated in 9-day-old embryonated chicken eggs from
specific-pathogen-free flocks (Beijing MERIAL Ltd.), at 37◦C
for 2 days. Allantoic fluid was clarified by centrifugation and
stored at −80◦C until use. Virus titer was determined by
plaque assay. A549, MDCK, and HEK293T cells were routinely
maintained in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10% fetal bovine serum, 100 µg/mL
penicillin-streptomycin (HyClone, USA) and cultured at 37◦C
with 5% CO2. Cells were transiently transfected with Lip2000
transfection reagent (Invitrogen, USA). The dual expression
plasmid constructs pcDNA5/FRT/TO/HA-MEK1/IRES/myc-
Ubc9 (HA-MEK1-Ubc9), pcDNA3.1-Flag-SUMO1 (SUMO2/3,
SUMO4), pcDNA3.1-Myc-Ubc9, and pcDNA3.1-HA-MEK1
were constructed by add-on PCR by insertion between BamHI
and XhoI sites of the pcDNA3.1(+) vector (Invitrogen). The
MEK1K64R mutant was generated by replacing lysine (K) 64 with
arginine (R).
HA-Surface Expression
MDCK cells were infected with different strains of influenza
A virus as indicated (MOI = 1). Cells were incubated for 8
h. Then, the cells were detached with trypsin, fixed in PBS/4%
paraformaldehyde, and a stepwise incubation with anti-H5-
HA mAb and then with anti-mouse FITC-conjugated mAb
(Calbiochem) each proceeded for 30 min on ice. Finally, HA-
surface expression was determined by FACS analysis using an
FACS Calibur (BD Biosciences).
Immunoprecipitation and Immunoblotting
A concentration of 2 × 106 cells were lysed in 250 µL of ice-
cold immunoprecipitation buffer (20 mM Tris-HCl, pH 8.0,
250 mM NaCl, 0.5% NP-40,3 mM EDTA, 0.1% SDS) freshly
supplemented with 20 mM N-ethylmaleimide (NEM) and 5 mM
iodoacetate (IAA) (Sigma, USA), 1 mM DTT (Sigma, USA)
and complete protease inhibitor cocktail (Roche). Cell lysates
(100 µg proteins) were then immunoprecipitated with indicated
antibodies, and the proteins were separated with 7.5% SDS-PAGE
for immunoblotting and visualized by a chemiluminescence
reagent (Thermo, USA).
Isolation and Enrichment of SUMOylated
Proteins
The isolation and enrichment of SUMOylated proteins were
performed with the SUMO-Qapture-T kit according to the
manufacturer’s instructions (Enzo, USA). Samples were prepared
under native conditions in order to allow efficient binding of
SUMO modified proteins to the SUMO-Qapture-T matrix. The
eluted SUMO-protein conjugates were analyzed by LC-MS/MS
(chip cube, Agilent Technologies, Waldbronn, Germany).
SUMOylation Assay
The in vitro SUMOylation assay kit was performed according
to the manufacturer’s instructions (BIOMOL, Goettingen,
Germany). Briefly, reactions contained E1 enzyme (250 ng
SAE1/SAE2), E2 enzyme (1.2 µg Ubc9), SUMO-1 or SUMO-
2 protein (5.7 µg) and GST-fusion liker protein (5 µg) in the
SUMOylation reaction buffer (55 mM Tris at pH 7.5, 5.5 mM
MgCl2, 2.2 mMATP, 5.5 mMDTT; dithiothreitol) and incubated
at 37◦C for 4 h. The reaction was terminated by adding 15 µl
2 × SDS-PAGE loading buffer and boiling at 95◦C for 5 min.
Samples were separated by probing with anti-SUMO1 antibody
(Santa Cruz Biotechnology, Heidelberg, Germany) (1:1000) and
detected by the ECL-plus detection system (GE Healthcare Bio-
Sciences). Antibodies were washed out and the sample was
reprobed with rabbit anti-SUMO-1 antibody (CST cell signaling
technology).
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Cell Treatment and Immunoprecipitation of
SUMOylated MEK1
Cells were treated with phorbol-12-myristate-13-acetate PMA
(Sigma, USA). To detect SUMO-MEK in vivo, precleared cell
lysates were rotated with anti-MEK1 antibodies at 4◦C for 12
h. Immunoprecipitates, collected on protein A Sepharose, were
washed 5 times with lysis buffer and subjected to SDS-PAGE
and immunoblotting. For SUMOylated MEK1 detection in cells
transiently transfected with HA-MEK1 and Flag-SUMO1, cell
lysates were incubated with an anti-HA antibody (Cell Signalling
Technology), precipitated with protein G Sepharose, washed 5
times with lysis buffer and analyzed by immunoblotting.
In situ Co-immunoprecipitation Assay
HEK293 cells were transiently transfected with the appropriate
plasmids and were lysed. Precleared cell lysates were incubated
with an anti-Flag mAb (Cell Signalling Technology), then bound
to protein G-Sepharose, and washed 4 times. Proteins were
separated by SDS-PAGE, and immunoblotted with the indicated
antibodies. To detect the endogenous MEK1-Ubc9 interaction,
the precleared lysates were incubated with anti-MEK1 antibody
at 4◦C for 6 h. The immunoprecipitates were immunoblotted as
described above.
qRT-PCR Quantification of NP Gene
Specific mRNA
A549 cells were harvested and total RNA was extracted
using Trizol reagent (GIBCO, USA). The RNA was reversely
transcribed into cDNA using M-MLV reverse transcriptase
(Promega, USA) and a poly-T oligonucleotide primer (5′-
TTTTTTTTT TTTTTT-3′, Takara, Japan). The levels of
NP mRNA transcripts were determined by quantitative
real-time PCR using the SYBR Premix Ex Taq Kit (Takara).
The PCR reactions (20 µL) were made in duplicate,
performed at 95◦C for 30 s, and subjected to 40 cycles of
95◦C for 5 s and 60◦C for 20 s on a Mx 3000P (Stratagene,
USA). The sequences of the special primers were forward
5′-TTCATCAGAGGGACAAGA GTGG-3′ and reverse 5′-
TCAGTTCAAGAGTGTTGG AGTC-3′ for NP (109 bp) and
forward 5′-ATGTATCAGTTGTGGATCTGACCTG-3′ and
reverse 5′-ATGCCTGCT TCACTACCTTCTTG-3′ for GAPDH
(86 bp). The relative levels of NP mRNA transcripts for the
control of GAPDH were analyzed with MxPro Q-PCR software
and calculated by the double standard curve method.
RESULTS
H5N1 Virus Infection Down Regulates
MEK1 SUMOylation
To determine whether influenza virus infection affects
the status of the host SUMOylation, A549 cells
were infected with a high pathogenic virus strain
[A/environment/Qinghai/1/2008(H5N1)] at a multiplicity
of infection (MOI) of 7, and virus-infected cells were collected
at 4, 8, 12, and 24 h post infection (p.i.) and subjected to
immunoblotting analysis against SUMO1, Ubc9, SAE1, SAE2,
and GADPH specific monoclonal antibodies. Compared to
MOCK-infected cells, a predominant proportion of cellular
SUMOylations increased substantially, but a small proportion
of deconjugated SUMO increased at 4 h p.i. and then decreased
slightly at 8 and 24 h post infection (Figure 1A). However, the
cellular level of the SUMO conjugating enzyme Ubc9 did not
demonstrate a corresponding increased (Figure 1A).
To identify differentially downregulated SUMOylated
proteins involved in influenza virus infection, we used the
A549 cell line to detect SUMO1 according to a previous report
(Xu et al., 2011). Purification of differentially SUMOylated
proteins coupled with LC-MS/MS identification was employed
to investigate the potential changes of SUMOylated proteins
in A549 cells in response to H5N1 virus infection (Figure 1B).
Furthermore, we predicted the SUMO target by using the
SUMOsp2.0 and SUMOplot Analysis Program. The results
showed that K64 of MEK1 had the primary potential SUMO1
acceptation site 64, bearing the consensus motif of ψKxE,
confirming MEK1 as a potential SUMO target (Figure 1C).
Taken together, the host protein, MEK1 as a possible SUMO
target, substantially decreased after H5N1 infection and the
SUMOylation status of MEK1 might be important for influenza
virus propagation.
MEK1 Interacts with Ubc9 and Its
SUMOylation Is SUMO1 Specific
As known, MEK1 as one of the two kinases, plays an important
role in activation of the ERK-MAPK pathway (Kranenburg
et al., 1999), which can be modified by influenza virus
infection. SUMOylation sometimes requires direct interaction
between Ubc9 and target proteins in order to transfer SUMO
moiety from E1 to the substrates. To investigate whether
MEK1 is in direct interaction with Ubc9, we co-transfected
MEK1, Ubc9, and SUMO1 plasmids into HEK293 cells for
48 h, then immunoprecipitated Ubc9 by anti-Ubc9 antibody
to finally determine whether MEK1 could be Co-IP or not.
The results showed that MEK1-Ubc9 fusion protein can
effectively utilize the cellular free SUMO1 protein, which lead to
overexpression of MEK1SUMOylation through co-transfection
and immunoprecipitation (Figure S1). We also found that
MEK1 interacts directly with Ubc9 in the presence of SUMO1
(Figure 2A).
Furthermore, to determine whether the MEK1 undergoes
SUMOylation in vivo, we expressed HA-MEK1 together
with each one of the three Flag-tagged SUMO isoforms
(SUMO1, SUMO2/3, and SUMO4) in HEK293 cells. HA-
MEK1 was immunoprecipitated, separated by SDS-PAGE
and immunoblotted with anti-HA or anti-Flag monoclonal
antibodies (Figure 2B). A slower-migrating form of HA-
MEK1/2, which was immunoreactive with the anti-Flag mAb,
was detected only when co-transfected with SUMO1, indicating
SUMO1 modification of MEK1. SUMO1 modification of
endogenous MEK1 was observed in cells (Figures 2C,D).
Taken together, these results suggest that MEK1 was specifically
modified by SUMO1.
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FIGURE 1 | SUMOylation of MEK1 is decreased in A549 cells after H5N1 influenza virus infection. (A) A549 cells were infected with H5N1 at an MOI of 7,
total cell extracts were collected at 4, 8, 12, and 24 h post infection, and analyzed by SDS-PAGE and western blotting using MAbs to SUMO1, Ubc9, SAE1, SAE2,
and an internal control GAPDH. (B) Identification of the MEK1 SUMOylation site by LC-MS/MS analysis. (C) Alignment of MEK1 N-terminal amino acids from human
and mouse. Bold and underlined text highlights the conserved LKDD motif.
SUMOylation of MEK1 Downregulates
Raf/MEK/ERK Signaling
Although highly reversible and dynamic, a small proportion of
SUMO conjugation results in a significant functional alteration of
substrate protein through inter- or intra-molecular interactions
(Geiss-Friedlander and Melchior, 2007). To determine whether
MEK1 SUMOylation affects the Raf/MEK/ERK (MAPK) signal
cascades, we compared the phosphorylating activity of ERK in
wild-type cells with MEK1 and mutant cells with SUMOylation-
defective MEK1K64R which was generated by deactivating the
SUMO binding site residue 64 in MEK1. Results showed that
the phosphorylating activity of ERK was significantly higher in
the mutant than that in wild-type cell (Figures 3A,B), indicating
that SUMOylation significantly attenuates MEK activity in
normally growing cells. In addition, we also found that MEK1
SUMOylation affects physiological processes for which the ERK
pathway is crucial. Following phorbol-12-myristate-13-acetate
(PMA) stimulation, HEK293 cells that express HA-MEK1K64R
elicited stronger ERK phosphorylation than cells that express
wild type HA-MEK1 (Figures 3C,D), but overexpression of
the MEK1-Ubc9 fusion protein did not exert a significant
effect on MEK1 phosphorylation under the stimulation of
PMA (Figure S2). Taken together, these data indicate MEK1
SUMOylation down regulates cellular functions mediated by
ERK signaling.
SUMOylation of MEK1 Negatively Controls
the H5N1 Virus Propagation
The influenza virus-induced Raf/MEK/ERK signal pathway is
crucial for efficient virus replication, and blockade of this
pathway reduces virus titers (Marjuki et al., 2007). To understand
whether influenza virus infection can manipulate MEK1
SUMOylation, we measured endogenous MEK1 SUMOylation
in virus-infected A549 cells. Surprisingly, MEK1 SUMOylation
was almost completely abrogated in cells infected with influenza
virus compared to in the MOCK cells without viral infection
(Figure 4A). To examine whether overexpression of MEK1
SUMOylation would alter the outcome of virus infection,
we constructed a dicistronic plasmid, HA-MEK1-Ubc9, which
contains a sequence coding for an N-terminally HA-tagged
MEK1 protein, the internal ribosome entry sites (IRES) from
the encephalomyocarditis virus (EMCV), and N-terminally
Myc-tagged Ubc9 protein (Figures 2A,C). We took advantage
of the stable expression of HA-MEK1-Ubc9 in HEK293 cell
to investigate whether overexpression of MEK1 SUMOylation
can affect influenza virus propagation. After infection with
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FIGURE 2 | MEK1 interacted with Ubc9 for SUMO1 conjugation. (A) Cells lysates were immunoprecipitated with anti-c-Myc antibody and immunoblotted with
anti-HA or Myc antibody. (B) HEK293 cells were co-transfected with HA-MEK1 and one of the Flag-tagged SUMO isoforms. Immunoprecipitated HA-MEK1 was either
blotted with an anti-HA antibody or was probed for SUMOylation using an anti-Flag antibody. SUMO1 modification of endogenous MEK1 was observed in cells (C,D).
an MOI of 7 [A/environment/Qinghai/1/2008(H5N1)], the
endogenous ERK pathway was decreased in HEK293 cells
expressed stably HA-MEK1-Ubc9 (Figure 4B). Simultaneously,
the NP gene of the influenza virus was also decreased
by 40.5%, which indicated that the virus propagation was
significantly inhibited (Figure 4C). Stable expression of HA-
MEK1-Ubc9 in A549 cells also downregulated endogenous ERK
phosphorylation after H5N1 infection (Figure 4D). Additionally,
we employed the stable expression of the HA-MEK1K64R-
Ubc9 fusion protein in HEK293 cell to examine whether the
mutation affects the H5N1 virus infection. After infection with
an MOI of 10, HEK293 cells stably expressing HA-MEK1K64R-
Ubc9 significantly upregulated the endogenous ERK pathway
(Figure 4B) and the NP gene of H5N1 virus was increased
by 110% indicating that the H5N1 propagation was enhanced
(Figure 4C). Taken together, these data showed that MEK1
SUMOylation negatively regulates H5N1 propagation by ERK
signaling.
HA Triggers the Switch from MEK1
SUMOylation to Phosphorylation in ERK
Pathway
The virus-induced MAPK signaling is activated late in the viral
replication cycle, and RNP nuclear export is dependent on this
cellular function (Pleschka et al., 2001; Ludwig et al., 2004).
Membrane accumulation of influenza A virus hemagglutinin
(HA) triggers nuclear export of the viral genome via protein
kinase Cα-mediated activation of ERK signaling (Marjuki et al.,
2007). To determine whether HA can play a role in the
relationship between SUMOylation and phosphorylation of
MEK1 in the ERK pathway, we constructed the expression
vector pCAGGS-QH-HA expressing the QH wtH5-HA, and
the MEK1-expression vector pKRSPA-HA-MEK1 (described
previously, Ludwig et al., 1996, 1998) were used for transfection
of MDCK cells. We found that the HA-membrane accumulation
promoted the level of MEK1 phosphorylation and decreased
the level of MEK1 SUMOylation at 1 h post infection,
and the level of MEK1 SUMOylation reached a valley and
the level of MEK1 phosphorylation reached a peak at 2 h
post infection (Figure 5A and Figure S3). Furthermore, virus
infection can also trigger a similar trend for MEK1 SUMOylation
and phosphorylation (Figure 5B). Taken together, in normal
cells, MEK1 SUMOylation attenuates the activity of MEK1
toward ERK, thereby inhibiting the ERK pathway. However,
virus infection can induce the activation of ERK signaling by
decreasing the MEK1 SUMOylation and increasing the MEK1
phosphorylation (Figure 5C).
DISCUSSION
Post-translational modifications provide a key functional
regulatory link between the virus and host cell. Influenza
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FIGURE 3 | HEK293 cells were transfected with HA-MEK1K64R mutant and wild-type HA-MEK1. (A) The expression levels of phospho-ERK and HA-MEK.
(B) Phosphorylating activity of ERK was significantly higher in the mutant than in the wild type cell. (C,D) Cells that expressed HA-MEK1K64R elicited stronger ERK
phosphorylation than cells that express wild type HA-MEK1. P values were calculated using a Student’s t-test. *P < 0.05; **P < 0.01.
FIGURE 4 | SUMOylation of MEK1 negatively regulates virus propagation. Cells infected by influenza virus showed almost completely inhibited MEK1
SUMOylation compared to MOCK cells without virus infection (A). The endogenous ERK pathway was downregulated in HEK293 cells that stably expressed
HA-MEK1-Ubc9 (B). The NP gene expression level of influenza virus was downregulated significantly (C). The endogenous ERK phosphorylation was downregulated
by stable expression of HA-MEK1-Ubc9 in A549 cells after virus infection (D). P values were calculated using a Student’s t-test. *P < 0.05; **P < 0.01.
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FIGURE 5 | A schematic model of negative regulation of the ERK pathway by MEK1 SUMOylation. The dynamic changes of MEK1-SUMOylation
and—phosphorylation show a similar trend for membrane expressing HA (A) and virus infection (B), but the crossover point between treatments for virus infection
appears 1 h later than when the membrane expresses HA. We propose a model that influenza virus activates the ERK pathway by negatively controlling MEK1
SUMOylation (C). HA of influenza virus is essential for regulation of vRNP export in the ERK pathway through down regulation of MEK1 SUMOylation, namely, HA
triggers the switch from MEK1 SUMOylation to phosphorylation of the ERK pathway and facilitates its infection.
virus infection can cause an increase of cellular SUMOylation,
suggesting that SUMOylation plays an important role in virus-
host interaction. The identification of SUMO targets affecting
viral infection is fundamental to our understanding of virus-
host interactions. Previous studies have demonstrated that the
influenza viral proteins NS1, NS2, PB1, NP, and M1 are bona fide
SUMO targets during viral infection (Pal et al., 2011). However,
the mechanism underlying the interplay between host cellular
SUMOylation proteins and influenza virus still remains unclear.
In this study, we identified that MEK1, as a novel SUMOylation
target protein after viral infection, physically interacts with Ubc9,
and functions as a negative regulator in influenza virus-induced
Raf/MEK/ERK signaling pathway. Our results show that MEK1
is modified specifically by SUMO1, and MEK1 SUMOylation
down regulates the Raf/MEK/ERK pathway. In addition, we
provided evidence to support that MEK1 functions in concert
with Ubc9 to suppress ERK signaling, thereby negatively
controlling influenza virus. Importantly, our findings suggest
that MEK1 SUMOylation represses Raf/MEK/ERK signaling
pathway, thereby downregulating influenza virus multiplication.
Thus, our study not only uncovers a novel mechanism by which
influenza virus hijacks the cellular SUMOylation pathway for
its propagation but also provides novel insights into the link
between host cellular SUMOylation and influenza virus infection
(Figure 5).
SUMO modification is a highly reversible and dynamic
process, the SUMOylation status of several target proteins
changes markedly in response to various stimuli and/or
depending on their subcellular localization (Dadke et al., 2007).
We noted that the mutant form of MEK1, MEK1K64R, is
resistant to MEK1 SUMOylation, thereby activating the ERK
signaling pathway. Indeed, the MEK1K64R mutant was more
potent than their wild-type MEK1 in activating ERK in vivo.
Therefore, inhibition of MEK1 activity by SUMOylation, in
concert with protein phosphatase-mediated inhibition, may
control the magnitude and duration of ERK activity. The
regulation is biologically important because the magnitude and
duration of ERK activity are critical determinants of cell fate, such
as differentiation, growth and survival.
Influenza viruses exploit host cell SUMOylation machinery
for their own propagation (Marusic et al., 2010; Wu et al.,
2011; Xu et al., 2011). Small hepatitis delta antigens
(S-HDAg) are modified by the SUMO-1 protein and then
SUMOylated S-HDAg selectively enhances HDV genomic
RNA and mRNA synthesis but not antigenomic RNA synthesis
(Tseng et al., 2010). Viroplasm proteins of rotavirus are also
SUMOylated to modulate virus replication (Campagna et al.,
2013). Epstein–Barr virus utilizes the cellular SUMOylation
system for its own benefit (Murata et al., 2010; Callegari
et al., 2014). SUMOylation of nonstructural 5A protein
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regulates hepatitis C virus replication by cellular SUMO
modification system in both HEK293T cells and Huh7.5
cells (Lee et al., 2014). Adult T-cell leukemia/lymphoma
(ATL) response to arsenic/interferon therapy is triggered by
PML-dependent hyper-SUMOylation by small ubiquitin-like
modifier (SUMO)2/3, ubiquitination by RNF4, and proteasome-
dependent degradation (Dassouki et al., 2015). Therefore,
SUMOylation is one of the post-translational modifications
involved in many cellular processes, including transcription
activity, protein stability, nuclear-cytosolic localization and
protein–protein interaction (Meulmeester and Melchior,
2008).
Influenza A virus is responsible for millions of infections
and thousands of deaths in the human population worldwide
each year. It extensively exploits and manipulates host cell
functions to support viral replication, and therefore, uncovering
these dependencies could help to develop new strategies for
antiviral therapy. We showed that influenza virus H5N1-
induced activation of the Raf/MEK/ERK cascades inhibited
MEK SUMOylation to enhance viral replication. Given the well-
defined role of the ERK pathway in influenza virus infection,
therapeutic targeting of ERK signaling components is an area
of intense investigation. It may be feasible to specifically block
ERK signaling by augmentation of MEK SUMOylation, thereby
providing a novel strategy for antiviral control of the virus.
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Figure S1 | Dicistronic expression constructs HA-MEK1-Ubc9 used in this
study. MEK1-Ubc9 fusion protein can effectively utilize free intracellular SUMO1
molecules and cause overexpression of MEK1 SUMOylation (A); the
immunoprecipitation results showed that the co-transfection expression vector of
MEK1-Ubc9 can be combined with intracellular SUMO1 molecules (B).
Figure S2 | MEK1 SUMOylation can be phosphorylated in vitro.
HA-MEK1-Ubc9 was immunoprecipitated from stably transfected HEK293 cells
that were treated with PMA (10 µg/ml) for the indicated times and were probed
with phospho-MEK1 (P-MEK1) or anti-HA (HA) antibodies (A). The intensity of the
P-MEK1bands was quantified (B).
Figure S3 | Analysis of HA-Surface Expression. A549 cells were infected with
influenza A virus as indicated (m.o.i. = 1). Cells were incubated for 8 h. Then, the
cells were detached with trypsin, fixed in PBS/4% paraformaldehyde, and
stepwise incubated with anti-H5-HA mAb and then with anti-mouse
FITC-conjugated mAb (Calbiochem) for 30 min on ice each. Finally, HA-surface
expression was determined by FACS analysis using an FACS Calibur at 3, 6, 9,
and 12 h.
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